Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Understanding which cash back card offers the most rewards can help you maximize your earnings. Explore your best options now!
27,114 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
The Midwest is driving the national housing surge, with absorption outpacing supply. Detroit, Chicago and Cleveland s...
A small auto-enrollment default in 401(K) plans can cost the average saver hundreds of thousands over a lifetime, a n...
IDEO, long seen as the oracle of human-centered design, is rethinking its business model in a world where AI standard...
Growth-focused SPYG has outpaced SPYV over the last decade, a trend supported by AI spending and mega-cap tech. The g...
China is reshaping higher education by cutting arts degrees to prioritize AI-ready programs. Industry leaders urge fa...
Fraudsters increasingly impersonate seniors to access bank funds. Learn how the posed elderly account holder scam unf...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
As Flotek prepares for its Q3 2025 earnings, investors will parse management tone, margins, and guidance. This articl...
From AI tools reshaping research to currency risk and the tug of timing, the Rule Breaker Investing Mailbag surfaces ...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
Analysts warn that grok could undermine spacex as AI bets shape risk appetite for a potential SpaceX IPO. Investors a...